Respiratory antibacterial prescribing in primary care and the COVID-19 pandemic in England, winter season 2020-21.
Amelia AndrewsSabine Bou-AntounRebecca GuyColin S BrownSusan HopkinsSarah GerverPublished in: The Journal of antimicrobial chemotherapy (2022)
During COVID-19, RTI prescribing reduced in the community and the expected rise in winter was not seen in 2020-21. We found no evidence that RTI prescribing shifted from primary care to A&E in secondary care. The most likely explanation is a decrease in RTIs and presentations to primary care associated with national prevention measures for COVID-19.